We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bill Would Cut Use Of 30-Month Stay In Drug Suits

Law360 (March 6, 2006, 12:00 AM EST) -- Proposed legislation on Capitol Hill would raise the stakes in disputes between the pharmaceutical industry and generic drug manufacturers, with approval sure to reduce court-approved delays that keep generics off the market while being litigated.

Senate bill 2300, the “Lower Priced Drugs Act,” is intended to stem suspected abuse by the pharmaceutical industry of the 30-month stay. The stay is often granted to prevent approval of generic drugs by the U.S. Food and Drug Administration until the lawsuit is resolved.

The bill would also cut in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.